Docket #: S21-232
Generation of neural organizer organoids and midline assembloids from human pluripotent stem cells
Stanford inventors have developed a method of using human induced pluripotent stem (hiPS) cells to generate three-dimensional neural floorplate organizers that are functionally active and capable of choreographing midline brain development. These floorplate organoids can be fused with spinal cord organoids to form midline assemboids to induce specific cell fate and cell-cell interactions at the interface.
Organizer cell populations are crucial to neurodevelopment as they control spatial patterning and neural connectivity by establishing signaling gradients of guidance molecules. Disruptions in organizer cell type function can lead to neuropsychiatric disorders. Due to the lack of access to neural tissues, the investigation of human organizers is limited. Currently, there is no in vitro generated three-dimensional floorplate organoid described to date.
This first-time generation of functional neural organizers from hiPS cells brings new opportunities in biological investigation of human organizers and neurodevelopment. This powerful platform can be used to model human neurodevelopment, study human neurodevelopment related genetic disorders, identify toxic molecules that affect brain development, and screen for therapeutics for neural defects.
Stage of development
Proof of concept
Applications
- Model human neurodevelopment
- Study genetic disorders of neurodevelopment
- Identify toxic molecules that disrupt neurodevelopment
- Screen for therapeutics
Advantages
- Novel
Publications
- Onesto, Massimo M. et. al. Midline Assembloids Reveal Regulators of Human Axon Guidance. bioRxiv Preprint June 2024
Related Links
Patents
- Published Application: WO2023137200
Similar Technologies
-
Intranasal vasopressin to treat social impairments associated with autism S18-301Intranasal vasopressin to treat social impairments associated with autism
-
Genome Editing of Human Neuronal Stem Cells (NSCs) to Treat Genetic Diseases of the CNS, Neural Injury, and Neurodegenerative Diseases S16-009Genome Editing of Human Neuronal Stem Cells (NSCs) to Treat Genetic Diseases of the CNS, Neural Injury, and Neurodegenerative Diseases
-
An integrated preclinical screening platform to identify novel empathogenic drugs and compounds S21-419An integrated preclinical screening platform to identify novel empathogenic drugs and compounds